Non-invasive Cardiac Output Monitoring in Obstetric Patients
Withdrawn before enrolling · Phase 4
Conditions studied: Complications; Cesarean Section, Anesthesia; Adverse Effect, Spinal and Epidural
In brief
The investigators hypothesize that continuously measuring stroke volume (SV) and cardiac output (CO) will 1) reveal hemodynamic instability in a timely manner and alert the physician promptly, 2) provide information for the physician to make the differential diagnosis as to whether the hemodynamic instability was due to vasodilatation or reduction of venous blood return, and 3) lead to appropriate and prompt treatment to improve patient outcome. -determine the SV and CO and their kinetic change using ICON® to establish a hemodynamic profile of the patient under spinal anesthesia for cesarean section. To determine if using instantaneous measurements of SV and CO to guide patient management improves hemodynamic stability.
Key facts
- Study ID
- NCT01516697
- Run by
- Massachusetts General Hospital
- People needed
- 0
- Starts
- 2011-10-01
- Expected to finish
- 2012-09-01
- Last updated by the study team
- 2017-01-18
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- age 18-45;
- receiving spinal anesthesia or combined spinal and epidural anesthesia to undergo cesarean section
You may not qualify if…
- Patients who have major cardiovascular disease,preexisting of hypertension or gestational hypertension, preeclampsia and body mass index greater than 35kg/m2;
- Patients who have skin lesion at the place where the electrode is supposed to be applied;
- Emergency cesarean section patients.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.